![]() |
|
|
Vol. 56, Issue 2, 429-433, August 1999
Laboratory of Neurosciences,
| |
Summary |
|---|
|
|
|---|
Kainate receptors are a subtype of ionotropic glutamate
receptors, permeable to cations and thus expected to have an excitatory depolarizing action on neurons. However, kainate receptor activation inhibits
-aminobutyric acid release in the hippocampus through activation of protein kinase C in a pertussis toxin-dependent manner,
suggesting a coupling of kainate receptors to G proteins. Thus, we
directly investigated the G protein coupling of kainate receptors in
the rat hippocampus by using a selective kainate receptor agonist,
[3H](2S,4R)-4-methylglutamate
([3H]MGA). [3H]MGA bound to a single site
to hippocampal membranes with a KD value of
32 nM and a Bmax value of 1024 fmol/mg
protein. This binding likely represents kainate receptors because it
was displaced by domoate (Ki = 4 nM),
kainate (Ki = 11 nM), and
6-cyano-7-nitroquinoxaline-2,3-dione (Ki = 1.4 µM), but not by
-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (Ki > 10 µM),
(RS)-
-methyl-4-phosphonophenylglycine
(Ki > 10 µM), or
(±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid
(Ki > 10 µM).
Guanylylimidodiphosphate (30 µM), which uncouples all G
protein-coupled receptors, shifted to the right the saturation curve of
[3H]MGA (KD = 133 nM).
This effect was mimicked by pretreatment of hippocampal membranes with
modifiers of Gi/Go proteins [30 µM
N-ethylmaleimide (KD = 98 nM) or 25 µg/ml pertussis toxin
(KD = 95 nM)] but not by a modifier of
Gs proteins [50 µg/ml cholera toxin
(KD = 32 nM)]. Treatment of
solubilized hippocampal membranes with pertussis toxin (25 µg/ml)
decreased [3H]MGA affinity
(KD = 105-113 nM), which was recovered
by reconstitution of these pretreated solubilized hippocampal membranes
with Gi/Go proteins
(KD = 41-76 nM). These results
indicate that hippocampal kainate receptors are coupled to
Gi/Go proteins.
| |
Introduction |
|---|
|
|
|---|
In
the central nervous system, fast, excitatory transmission is mostly
mediated by glutamate acting on postsynaptic ionotropic glutamate
receptors of the
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) and N-methyl-D-aspartate
subtypes (Hollmann and Heinemann, 1994
). A third subtype of ionotropic
glutamate receptors, kainate receptors, has been identified by both
pharmacological and molecular genetic approaches (Hollmann and
Heinemann, 1994
; Bettler and Mulle, 1995
), but their role is just
starting to be revealed. It is still a matter of debate whether kainate
receptor activation participates in fast synaptic transmission and/or
in presynaptic modulation of neurotransmitter release (Lerma et al.,
1997
; Malva et al., 1998
). One likely role for kainate receptors in the
hippocampus is the modulation of GABAergic transmission (Clarke et al.,
1997
; Rodríguez-Moreno et al., 1997
; Cossart et al., 1998
;
Frerking et al., 1998
), which is essential for the control and
coordination of hippocampal excitability (Buckmaster and Soltesz, 1996
)
and may be the basis of the profound epileptogenic and cytotoxic
effects of kainate in the hippocampus (Coyle, 1983
). This effect of
kainate on hippocampal GABAergic transmission might be due to a
combined postsynaptic modulation of spontaneous firing (Cossart et al., 1998
; Frerking et al., 1998
) and to a presynaptic inhibition of
-aminobutyric acid (GABA) release (Cunha et al., 1997
;
Rodríguez-Moreno et al., 1997
). This latter effect is
paradoxical in view of the expected excitatory depolarizing action of
kainate receptors, which are mostly permeable to cations (Bettler and
Mulle, 1995
). The observation that the mechanism through which kainate
receptors inhibit GABA release in the hippocampus is independent of ion channel current and is sensitive to pertussis toxin and to inhibitors of protein kinase C (Rodríguez-Moreno and Lerma, 1998
) raises the question of whether kainate receptors might also behave as metabotropic receptors.
Taking advantage of the recent introduction of a selective kainate
receptor agonist, (2S,4R)-4-methylglutamate (MGA;
Gu et al., 1995
; Toms et al., 1997
; Zhou et al., 1997
), we now report that kainate receptors in the hippocampus are coupled to
Gi/Go proteins, thus
providing a molecular basis for the inhibitory metabotropic action of
kainate receptor activation in the hippocampus (Rodriguéz-Moreno
et al., 1998
).
| |
Materials and Methods |
|---|
|
|
|---|
Drugs and Solutions.
[3H]MGA, MGA,
(±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid
(t-ACPD), and
(RS)-
-methyl-4-phosphonophenylglycine (MPPG) were
purchased from Tocris Cookson (Bristol, UK). Kainate,
N-ethylmaleimide, guanylylimidodiphosphate [Gpp(NH)p],
adenylylimidodiphosphate, and cholera toxin were purchased from
Sigma Chemical Co. (St. Louis, MO). Domoic acid, AMPA, and
6-cyano-2,3-dihydroxy-7-nitroquinoxaline (CNQX) were obtained from
Research Biochemicals Inc. (Natick, MA), and pertussis toxin and G
proteins from bovine brain were obtained from Calbiochem (La Jolla, CA).
Preparation of Membranes and Pretreatment with G Protein
Modifiers.
Membranes were prepared as described previously (Cunha
et al., 1999
). Briefly, two to four male Wistar rats (160-180 g) were sacrificed by decapitation after halothane anesthesia. The hippocampi were dissected out at 4°C and homogenized in 10 ml of sucrose solution (0.32 M) containing 50 mM Tris · HCl, 2 mM EGTA, and 1 mM
dithiothreitol (pH 7.6). The homogenates were centrifuged at
3000g for 10 min at 4°C, and the supernatants were
transferred to new tubes and centrifuged at 20,000g for 20 min at 4°C. The pellets were then resuspended in the incubation
solution containing 50 mM Tris · HCl and 0.5 mM
MgCl2 (pH 7.4) and maintained at 4°C (incubation buffer). In some experiments, hippocampal synaptosomes were
first prepared by sucrose/Percoll isopicnic centrifugations (Cunha et al., 1997
), and membranes were prepared after sonication of
the synaptosomes.
Reconstitution of [3H]MGA Binding with
Gi/Go Proteins in Pertussis Toxin-Pretreated
Membranes.
Hippocampal membranes were prepared as described above
and resuspended in a reaction buffer containing 50 mM Tris · HCl
with 0.5 mM MgCl2 (pH 7.4), 10 mM thymidine, 1 mM
ATP, 0.5 mM GTP, 10 mM dithiothreitol, and 2.5 mM
3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate (CHAPS).
Knockout of native Gi/Go
proteins and later reconstitution with exogenously added
Gi/Go proteins of
solubilized hippocampal membranes were performed as described
previously (Cunha et al., 1999
). Basically, pertussis toxin (25 µg/ml), preactivated as described above, and 1 mM
NAD+ were then incubated with membranes for 45 min at 37°C. The reaction was terminated by the addition of 10 ml
of ice-cold reaction buffer, followed by pelleting of the membranes by
centrifugation at 20,000g for 10 min at 4°C. As a control,
hippocampal membranes were subject to the same procedure but
without the addition of NAD.
Gi/Go proteins were
resuspended in a solution containing 50 mM HEPES (pH 7.6), 1 mM EDTA, 1 mM dithiothreitol, 20% glycerol, 0.05% phosphatidylcholine, and 12.5 mM 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate and added
to membranes (0.980-1.105 mg of protein) at a final concentration of
600 nM. After a 15-min incubation at 4°C, the membranes reconstituted
with G proteins were diluted 20-fold with the incubation buffer at
4°C. Saturation curves of [3H]MGA binding
were then performed in parallel in pertussis toxin-treated membranes
without or with NAD and without or with G proteins.
Binding Assays.
Binding of [3H]MGA
was for 90 min at 4°C with 190 to 370 µg of membrane protein in a
final volume of 300 µl in the incubation solution containing 50 mM
Tris · HCl and 0.5 mM MgCl2 (pH 7.4), essentially as described previously for
[3H]kainate (e.g., London and Coyle, 1979
) or
for [3H]MGA (Toms et al., 1997
). Under these
conditions, an apparent equilibrium of [3H]MGA
binding (30 nM) was reached after 45 min of incubation and binding
remained virtually unchanged up to 150 min (data not shown). Specific
binding was determined by subtraction of the nonspecific binding that
was measured in the presence of 100 µM kainate. The binding reactions
were stopped by vacuum filtration through Whatman GF/C glass-fiber
filters, followed by washing of the filters and reaction tubes with 8 ml of incubation solution, maintained at 4°C. The filters then were
placed in scintillation vials with 5 ml of scintillation liquid
(Scintran Cocktail T; Wallac, Turku, Finland). Radioactivity bound to
the filters was determined after 12 h with an efficiency of 55 to
60% for 2 min. Saturation curves were performed in triplicate with 10 different [3H]MGA concentrations ranging from
0.3 to 120 nM. Competition curves were performed in duplicate with 30 nM [3H]MGA and eight different concentrations
of competitors ranging from 1 nM to 10 µM. The amount of membrane
protein was determined according to the methods of Peterson
(1977)
. The data were initially processed in Microsoft Excel software
(Microsoft Corp., Redmond, WA) to determine the average specific
binding and then fitted by nonlinear regression with the Raphson-Newton
method, performed with the GraphPAD Software (San Diego, CA) InPlot
software package. When performing [3H]MGA
competition experiments, the IC50 values were
converted into Ki values on nonlinear
fitting of the semilogarithmic curves derived from the competition
curves, with the KD value for MGA derived
from saturation experiments. An F test (P > .05) was used to determine whether the curves were fitted best by one
or two independent binding sites. The values are presented as mean ± S.E.M. of n experiments, except
KD values, which are presented as mean
(95% confidence interval).
| |
Results and Discussion |
|---|
|
|
|---|
Saturation curves of [3H]MGA binding were
performed in hippocampal membranes (Fig.
1A). The fitting of the saturation
isotherm showed a single binding site for
[3H]MGA (F > 0.05 for two
binding sites in each individual experiment) with the average binding
parameters presented in Table 1. Notably, the apparent affinity of MGA found in the present study is similar to
that originally reported (Gu et al., 1995
) and is slightly lower than
the KD value for
[3H]MGA binding found in rabbit membranes (Toms
et al., 1997
). The inability to detect two affinity binding sites for
[3H]MGA (Toms et al., 1997
) may be related to
the presence of divalent cations in the incubation solution that
affects [3H]kainate binding (e.g., Honoré
et al., 1986
). The density of [3H]MGA-binding
sites in hippocampal membranes is similar to that of
[3H]kainate-binding sites (London and Coyle,
1979
).
|
|
We then compared the density of [3H]MGA binding
in whole hippocampal membranes with [3H]MGA
binding in membranes prepared from hippocampal synaptosomes, because it
has been proposed that kainate receptors might be predominantly presynaptically located (Coyle, 1983
; Malva et al., 1998
). As illustrated in Fig. 1B, [3H]MGA also bound to a
single binding site in hippocampal synaptosomal membranes
(F > 0.05 for two binding sites in each individual
experiment) with a KD value of 40 nM
(28-52 nM; n = 4), which was similar (P > .05) to that found in whole hippocampal
membranes. However, the density of [3H]MGA
binding, measured as Bmax, was
significantly (P < .05) higher in synaptosomal
(2692 ± 41 fmol/mg protein; n = 4) than in whole membranes from the hippocampus (1024 ± 39 fmol/mg protein;
n = 15). This confirms previous data obtained with
[3H]kainate (Foster et al., 1981
) and provides
a biochemical confirmation of previous neurochemical (for a review, see
Malva et al., 1998
), neurotoxic (Represa et al., 1997
), and
anatomic studies (Foster et al., 1981
), emphasizing the predominant
presynaptic location of kainate receptors in the hippocampus. This does
not exclude the simultaneous presence of functional postsynaptic
kainate receptors in the hippocampus (Castillo et al., 1997
; Clarke et
al., 1997
; Lerma et al., 1997
; Cossart et al., 1998
; Frerking et al.,
1998
; Vignes et al., 1998
).
One of the major characteristics of metabotropic G protein-coupled
receptors is the sensitivity of agonist binding to the state of the
receptor (i.e., coupled or uncoupled to G proteins), and this
equilibrium can be shifted toward uncoupled receptors by increasing the
concentration of GTP (Stiles et al., 1984
). We now observed that the
stable GTP analog Gpp(NH)p (30 µM) shifted to the right the
saturation curve of [3H]MGA binding (Fig.
1). As presented in Table 1, the effect of Gpp(NH)p was mostly
reflected by an increase in KD, with no
significant change in Bmax. In contrast,
adenylylimidodiphosphate (30 µM) was devoid of effect on
[3H]MGA binding because neither the
KD value (35-59 versus 42-48 nM) nor the
Bmax value (921-1089 versus 879-1089
fmol/mg protein) was modified by adenylylimidodiphosphate (30 µM).
The shift in KD caused by Gpp(NH)p,
quantified by the GTP shift [KD in the presence of Gpp(NH)p/KD in control
conditions], which is a measure of the coupling of receptor to G
proteins (Stiles et al., 1984
), is significantly (P < .05) larger than unity (Table 1). This strongly suggests that kainate
receptors in the mammalian brain can be coupled to G proteins, as has
previously been suggested for nonmammalian kainate-binding sites, which
have a shorter amino acid sequence than their mammalian counterparts
and do not exhibit ion channel activity (for a review, see Henley,
1994
).
Other glutamate receptors, such as metabotropic glutamate receptors
(Hollmann and Heinemann, 1994
) or AMPA receptors (Wang et al., 1997
),
also couple to G proteins. Despite previous evidences that MGA is a
selective ligand for kainate versus nonkainate glutamate receptors in
different systems (Gu et al., 1995
; Toms et al., 1997
; Zhou et al.,
1997
), we decided to exclude the possibility that the observed GTP
shift of [3H]MGA binding could be attributed to
binding of [3H]MGA to nonkainate glutamate
receptors in rat hippocampal membranes. Figure
2 shows that two kainate receptor
agonists, kainate and domoate, completely displaced
[3H]MGA (30 nM) binding with
Ki values of 11 and 4 nM (n = 3). A non-N-methyl-D-aspartate
ionotropic glutamate receptor antagonist, CNQX, also displaced
[3H]MGA (30 nM) binding, with a
Ki value of 1.4 µM (n = 3). In contrast, AMPA was unable to displace
[3H]MGA (30 nM) binding within the
concentration range tested (n = 3). This profile of
displacement of [3H]MGA binding (domoate
kainate
CNQX
AMPA) is fully compatible with binding of
[3H]MGA to kainate but not to AMPA receptors in
hippocampal membranes (Bettler and Mulle, 1995
). Finally, the
observation that a selective group I metabotropic glutamate receptor
agonist (t-ACPD) and a nonselective group II/group III
metabotropic glutamate receptor antagonist (MPPG) were virtually
ineffective displacers of [3H]MGA (30 nM)
binding (Fig. 2) excludes the measurable contribution of group I, II,
and III metabotropic glutamate receptors for
[3H]MGA binding to hippocampal membranes.
|
To further investigate whether a particular group of G proteins might
be coupled to kainate receptors, we tested the effect of pretreatment
of membranes with modifiers of G proteins (Yamane and Fung, 1993
) on
the binding of [3H]MGA to whole hippocampal
membranes. As presented in Table 1, the sulfhydryl alkylating agent
N-ethylmaleimide (30 µM), which uncouples
Gi and Go proteins by
interacting with the carboxyl-terminal cysteine residue found in the
subunit of Gi/Go
proteins (Yamane and Fung, 1993
), increased the
KD value of [3H]MGA
binding, with no significant change in
Bmax. Another modifier of
Gi/Go proteins, pertussis
toxin (25 µg/ml), which ADP-ribosylates a cysteine residue of the
subunit of Gi/Go proteins,
blocking their interaction with the receptors (Yamane and Fung, 1993
), also increased the KD value of
[3H]MGA binding, with no significant change in
Bmax (Table 1). However, a modifier of
another group of G proteins, cholera toxin (50 µg/ml), which
ADP-ribosylates arginine residues of
s,
inhibiting their intrinsic GTPase activity and resulting in continuous
activation of
s (Yamane and Fung, 1993
),
virtually did not affect [3H]MGA-binding
parameters (Table 1). These results suggest that Gi/Go proteins are likely
candidates to directly or indirectly couple to hippocampal kainate
receptors. These results also suggest that the effect of Gpp(NH)p is
likely due to its ability to activate G proteins rather than to
directly interact with hippocampal kainate receptors, as it has been
shown to occur in chick cerebellar kainate-binding protein (Paas et
al., 1996
). This was further confirmed by the ability of
N-ethylmaleimide to occlude the inhibitory effect of Gpp(NH)p on [3H]MGA binding. Thus, in
N-ethylmaleimide (30 µM)-treated membranes, the
KD value of [3H]MGA
binding was 120 to 139 nM in the absence and 95 to 132 nM in the
presence of Gpp(NH)p (30 µM).
To demonstrate the coupling of
Gi/Go proteins to kainate
receptors, we tested the ability of exogenously added
Gi/Go proteins to revert
the GTP shift of [3H]MGA binding caused by
pertussis toxin. As shown in Fig. 3, in membranes treated with pertussis toxin (25 µg/ml) in the presence of
NAD+, there was a decrease in
[3H]MGA binding compared with nontreated
membranes (i.e., treated with pertussis toxin in the absence of
NAD+). This was reflected by a change
(P < .05) in KD value from
46 nM (95% confidence interval, 27-89 nM) in nontreated solubilized membranes to a KD value of 108 nM (95%
confidence interval, 97-119 nM) in the presence of pertussis toxin (25 µg/ml) and NAD+ (n = 3). In
contrast, when the membranes pretreated with pertussis toxin and
NAD+ were reconstituted with
Gi/Go proteins, there was a
recovery of [3H]MGA binding to values close to
these found in nontreated membranes (Fig. 3), with an average
KD value of 56 nM (95% confidence
interval, 17-89 nM; n = 3). Finally, the binding of
[3H]MGA in nontreated membranes was not
markedly affected (P > 0.05) by the addition of
Gi/Go proteins
(KD = 57 nM; 95% confidence interval,
36-79 nM; n = 3; Fig. 3).
|
These results indicate that kainate receptors are coupled to G proteins
of the Gi/Go group in rat
hippocampal membranes and substantiate the proposal that the
presynaptic inhibition of GABA release by kainate receptor activation
in the hippocampus (Cunha et al., 1997
; Rodríguez-Moreno et
al., 1997
) involves a metabotropic transduction system
(Rodríguez-Moreno and Lerma, 1998
). This G protein coupling of
kainate receptors is also a candidate molecular basis for the
inhibition of synaptic transmission in the hippocampus (Vignes et al.,
1998
) or for the hyperpolarization of CA1 neurons caused by a kainate
receptor (GLuR5) agonist (Clarke et al., 1997
), with both effects being
difficult to reconciliate with the activation of ionotropic receptors
permeable to cations. However, kainate receptors have a topology
typical of ionotropic receptors (Bettler and Mulle, 1995
), making it
difficult to conceive a direct interaction with G proteins.
Alternatively, this interaction might be indirect because kainate
receptors are clustered into macromolecular signaling complexes
by SAP proteins (Garcia et al., 1998
), with some of these proteins,
like SAP-97, being presynaptic (Müller et al., 1995
). This
association of kainate receptors with the SAP-90/PSD-95 family controls
the rate of receptor desensitization (Garcia et al., 1998
) but might
also allow indirect coupling of kainate receptors with G proteins
because PDZ domains interact with different regulatory proteins,
namely with Ras GTPase activities (Kim et al., 1998
). However, it
remains to be demonstrated whether the interaction of kainate receptors
with SAP proteins allows coupling to G proteins or whether kainate
receptors couple directly to G proteins.
| |
Acknowledgments |
|---|
We acknowledge Drs. L. V. Lopes, J. Coelho, and A. R. Costenla for valuable assistance in the filtration assays. R. A. C. is indebted to Professor Moniz Pereira (Fac. Pharmacy of Lisbon) for scintillation counting facilities.
| |
Footnotes |
|---|
Received February 2, 1999; Accepted April 21, 1999
This work was supported by Fundação para a Ciência e Tecnologia (Praxis/2/2.1/SAU/1348/95).
Send reprint requests to: Dr. R. A.Cunha, Laboratory of Neurosciences, Faculty of Medicine, University of Lisbon, Avenida Prof. Egas Moniz, 1649-035 Lisbon, Portugal. E-mail: racunha{at}neurociencias.pt
| |
Abbreviations |
|---|
AMPA,
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
GABA,
-aminobutyric acid;
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate;
CNQX, 6-cyano-2,3-dihydroxy-7-nitroquinoxaline;
Gpp(NH)p, guanylylimidotriphosphate;
MGA, (2S,4R)-4-methylglutamate;
MPPG, (RS)-
-methyl-4-phosphonophenylglycine;
t-ACPD, (±)-1-aminocyclopentane-trans-1,3-dicarboxylic acid.
| |
References |
|---|
|
|
|---|
-aminobutyric acid release by kainate receptor activation in rat hippocampal synaptosomes.
Eur J Pharmacol
323:
167-172[Medline].This article has been cited by other articles:
![]() |
J. V. Negrete-Diaz, T. S. Sihra, J. M. Delgado-Garcia, and A. Rodriguez-Moreno Kainate Receptor-Mediated Inhibition of Glutamate Release Involves Protein Kinase A in the Mouse Hippocampus J Neurophysiol, October 1, 2006; 96(4): 1829 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hawkes, J. H. Jhamandas, K. H. Harris, W. Fu, R. G. MacDonald, and S. Kar Single Transmembrane Domain Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor Regulates Central Cholinergic Function by Activating a G-Protein-Sensitive, Protein Kinase C-Dependent Pathway J. Neurosci., January 11, 2006; 26(2): 585 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Huettner Spine-Tingling Excitement from Glutamate Receptors Sci. Signal., November 25, 2003; 2003(210): pe53 - pe53. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Crowder and J. L. Weiner Functional Characterization of Kainate Receptors in the Rat Nucleus Accumbens Core Region J Neurophysiol, July 1, 2002; 88(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lerma, A. V. Paternain, A. Rodriguez-Moreno, and J. C. Lopez-Garcia Molecular Physiology of Kainate Receptors Physiol Rev, July 1, 2001; 81(3): 971 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frerking, D. Schmitz, Q. Zhou, J. Johansen, and R. A. Nicoll Kainate Receptors Depress Excitatory Synaptic Transmission at CA3{right-arrow}CA1 Synapses in the Hippocampus via a Direct Presynaptic Action J. Neurosci., May 1, 2001; 21(9): 2958 - 2966. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||